Can the influence of karyotype in acute myeloid leukemia be overcome by high-dose chemotherapy?
Bradstock
Ken
K
Department of Haematology, Westmead Hospital, Westmead, Sydney, Australia. kbradstock@gmail.com
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016503:Drug Delivery Systems / Q000639:trends; D006801:Humans; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000235:genetics; D016896:Treatment Outcome
D000970:Antineoplastic Agents